Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Kidney transplantation is widely considered to be the treatment of choice for children with
End Stage Renal Disease (ESRD). The purpose of this study is to determine the safety of
sirolimus monotherapy for long-term immunosuppression in children and adolescents after
kidney transplantation.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)